Abigal Abrams of Time reports on CRISPR-Cas9 which is a “new method of genetic engineering that allows scientists to edit DNA with precision and relative ease.”
A group of Chinese scientists will be the first in the world to use the CRISPR-Cas9 gene-editing technology on humns in a clinical trial set to begin next month.
The team plans to start by testing cells in people with lung cancer, the science journal Nature reported. The trial received approval from the ethical review board at Sichuan University’s West China Hospital in Chengdu on July 6.
CRISPR is a powerful technology that has the potential to change human lives by allowing scientists to remove or edit genetic mutations responsible for incurable diseases.